IGBA Calls on all Stakeholders to Join the Biosimilars Movement on Advancing Access

Related Posts

• Advancing Medicines repurposing in the EU 14 March 2022 Repurposing has emerged as an important strategy to address unmet…
• Interview: Medicines for Europe Reports on EU Biosimilar… 27 July 2020 The Center for Biosimilars® (CfB) spoke with Adrian van den Hoven,…
• IGBA Launches First Global Biosimilars Week 16 November 2020
• Opinion piece by Christoph Stoller for Friends of Europe 3 June 2021 "Too much at stake in the EU pharma strategy to…